In this study, we first found decreased levels of CPEB2 in glioma, and then we proved that CPEB2 could inhibit glioma cells proliferation through upregulating p21 by specifically overexpressing the canonical isoform Q7Z5Q1-2. Here, CDKN1A is linked to glioma.